Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Browning West and Glenn Chamandy Comment on Gildan Activewear’s Defensive and Reactionary Board Refreshment
-
Seagate Drives Progress on Its Renewable Energy and Circularity Programs
-
Eric Sprott Announces Changes to His Holdings in Galleon Gold Corp.
-
BV Financial, Inc Announces Financial Results
-
Alterra Mountain Company Releases Its 2023 Impact Report
-
ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
-
Retail Investing Startup Midas Raises $45 Million to Roll Out Crypto, Mutual Fund, and Savings Account Products
-
Canadian Investment Regulatory Organization Trade Resumption - VLV
-
Lithium Argentina to Release First Quarter 2024 Results on May 13, 2024
-
The Transformative Power of Robotics Education in K-12 Schools
-
Innovative Industrial Properties to Report 2024 First Quarter Results
-
First Bank Announces First Quarter 2024 Net Income of $12.5 Million
-
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
-
EMGA secures US$ 15M financing for Banco Improsa in Costa Rica
-
LiveOne (Nasdaq: LVO) Anticipates Certain Record Q4 and FY24 Results
-
ImmPACT Bio to Present New Ex Vivo Preclinical Data for Bispecific Claudin 18.2/TGF-β CAR T Program at the American Society of Gene & Cell Therapy 27th Annual Meeting
-
Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society
-
Capsida Biotherapeutics to Present New Data on its Wholly Owned Gene Therapy Programs in Genetic Epilepsy and Parkinson's Disease at the Annual Meeting of the American Society of Gene & Cell Thera
-
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
-
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27t
-
Stonegate Updates Coverage on Isabella Bank Corporation (ISBA) 2024 Q1
-
Driven Brands Holdings Inc. to host first quarter earnings conference call on May 2, 2024
-
Canadian Investment Regulatory Organization Trade Resumption - WI
-
Community Bancorp. Reports First Quarter 2024 Earnings
-
Vesigen to Present New Preclinical Data on Engineered ARMMs Technology at 2024 ASGCT Annual Meeting
-
Media advisory - Minister Champagne highlights budget investments in Indigenous reconciliation
-
Mission Bancorp Reports First Quarter Earnings of $7.3 Million. Annual Loan Growth of 8.9%.
-
Affinia Therapeutics to Present Data on Novel Cardiotropic and BBB-Penetrant AAV Capsids and Preclinical Efficacy and Safety in Genetic Cardiomyopathies and Sporadic ALS at the American Society of Gen
-
Xigem Technologies Encouraged by Growth in Used Car Market: Driven by Technology
-
Ring Therapeutics Announces Presentations at the 27th Annual American Society of Gene and Cell Therapy
-
Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting
-
Alarming jump in working Victorians seeking homelessness help
-
Franklin Street Properties Corp. to Announce First Quarter 2024 Results
-
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
-
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
-
Pendulum PR Expands Public Relations and Communications Services with New Senior Vice President of Client Affairs
-
Bolt Medical Announces Completion of Enrollment of RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System
-
Freed-Hardeman University Appoints Batte and Rucker to Board of Trustees
-
SANMINA CORPORATION INVITES YOU TO JOIN ITS SECOND QUARTER FISCAL 2024 EARNINGS CONFERENCE CALL
-
Nucor Reports Results for the First Quarter of 2024
-
iLearningEngines Reports Fourth Quarter and Full Year 2023 Results
-
Stagwell (STGW) Announces May Investor Conferences at Needham, J.P. Morgan, and B. Riley Securities
-
PG&E Customers' Electricity 100% Greenhouse Gas-Free in 2023
-
ASUR Reports 1Q24 Financial Results
-
Cadence Bank Announces First Quarter 2024 Financial Results
-
Quaker Houghton Releases its 2023 Sustainability Report
-
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
-
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
-
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting

